Xarelto Injury Law Firms Selected for Leadership Positions by Judge Eldon Fallon
Xarelto attorney leadership positions have been selected for the Xarelto lawsuits previously filed, consolidated, coordinated and assigned to Judge Eldon Fallon. Out of 100 Xarelto injury lawsuits filed, Judge Fallon selected a group of plaintiffs’ attorneys to serve in a variety of leadership roles. Judge Fallon appointed twelve attorneys to leadership positions who are charged with various pretrial procedures including, but not limited to conducting discovery, speaking on behalf of plaintiffs at hearings and negotiating prospective settlements with defendants, Bayer, Janssen and Johnson & Johnson. The leadership roles were created to minimize duplicative discovery and to serve all parties involved without conflicting rulings from multiple judges.
Xarelto was approved in July of 2011 by the Food & Drug Administration and is one of the newest blood thinners on the market today. This drug belongs to a class of anti-coagulants that is marketed by both Bayer, Janssen and Johnson & Johnson to reduce the risk and formation of blood clots and stroke, treat deep vein thrombosis and pulmonary embolism, and to reduce the risk of blood clots in patients undergoing hip and knee replacement surgery. While the medication was intended to help, its adverse side effects were seemingly far more dangerous. Unfortunately, the serious and fatal side effects of this drug were not known until after patients began using it. One of the most dangerous side effects for people taking Xarelto includes death caused by uncontrollable bleeding. To date, there is no anti-dote for the bleeding nor is there an effective way to stop the bleeding.
The litigation process is not over, while Judge Fallon has about 100 cases, there are expected to be thousands more Xarelto lawsuits filed throughout the U.S. Since Xarelto litigation is rapidly growing, a selected group of claims will go through the discovery, deposition and trial process to see how juries respond to the cases. Judges can gauge the outcome of other potential Xarelto settlements based on the outcome of the group of claims that went before juries in the U.S. District Court.
Legal Commentary: The Xarelto lawyers at our firm are currently investigating claims for those affected by Xarelto. From a civil standpoint, our firm has represented thousands of individuals and families who have become victims to Xarelto or its side effects. If you or a loved one has experienced bleeding, blood clots, death or other serious complications while taking Xarelto, contact our pharmaceutical lawyers for a free consultation and case evaluation about your potential Xarelto lawsuit. You can reach us at 866.705.7584 or by email at email@example.com.
About the Author: Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Xarelto victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past five consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at firstname.lastname@example.org or by calling 1.866.705.7584.